KaydedilenlerDerginizi ekleyin

Dergiler / International Journal of Medical Biochemistry / 2021 / Cilt: 4 - Sayı: 2

Data to assist in the determination of biochemistry test ranges to assess hemodialysis efficacy in patients with chronic renal failure

Claudio ILARDO
Yoann EHRHARD
Olivier CALAS
Joel BARTHES
Sayfa
131–135
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: The establishment of specific ranges for dialysis patients could contribute to finding specific thresholds to monitor the effectiveness of HD.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: Reference intervals are usually defined based on blood samples from healthy subjects and specific refer ence ranges for patients on hemodialysis (HD) are not currently available.
📊
Temel Bulgular & Veri:Methods: The findings of the 4 most recent quarterly check-ups of 684 patients (233 women and 451 men; age 18-95 years) treated with HD in several dialysis units attached to a single laboratory were studied.
💡
Sonuç & Katkı:Conclusion: The establishment of specific ranges for dialysis patients could contribute to finding specific thresholds to monitor the effectiveness of HD.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: Reference intervals are usually defined based on blood samples from healthy subjects and specific refer ence ranges for patients on hemodialysis (HD) are not currently available. The aim of the study was to establish expect ed ranges of biochemical analytes before and after HD for patients with chronic renal failure (CRF). Methods: The findings of the 4 most recent quarterly check-ups of 684 patients (233 women and 451 men; age 18-95 years) treated with HD in several dialysis units attached to a single laboratory were studied. Biochemical analytes were measured using fully automated Roche Cobas C 501 or C 701 analyzers (Roche Diagnostics, Basel, Switzerland). Expect ed ranges were set according to International Federation of Clinical Chemistry and Clinical and Laboratory Standards Institute guidelines using the nonparametric method. Results: Compared with pre-HD values, beta-2 microglobulin (β2m), chloride, creatinine, phosphate, potassium, and urea concentrations were lower post-HD (p 10%) in the creatinine level between individuals under and over 60 years of age (p<0.0001). Conclusion: The establishment of specific ranges for dialysis patients could contribute to finding specific thresholds to monitor the effectiveness of HD.

🔖

Bu Makaleye Atıf Yap

ILARDO, C., EHRHARD, Y., CALAS, O., BARTHES, J. (2021). Data to assist in the determination of biochemistry test ranges to assess hemodialysis efficacy in patients with chronic renal failure. International Journal of Medical Biochemistry, Cilt: 4 - Sayı: 2, 131–135. https://ajindex.com/articles/415041

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Grasbeck R, Saris NE. Establishment and use of normal values. Scand J Clin Lab Invest, 1969;26(Suppl 110):62–3
  2. Treacy O, Brown NN, Dimeski G. Biochemical evaluation of kidney disease. Transl Androl Urol 2019;8(Suppl 2):214–23
  3. Dixon WJ. Processing data for outliers. Biometrics 1953;9:74– 89
  4. Clinical and Laboratory Standards Institute. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline. 3rd ed. Wayne, PA: CLSI; 2008. Available at: https://clsi.org/standards/products/method-evaluation/documents/ep28/. Accessed Mar 15, 2021
  5. Henny J, Vassault A, Boursier G, Vukasovic I, Mesko Brguljan P, Lohmander M, et al; Working Group Accreditation and ISO/ CEN standards (WG-A/ISO) of the EFLM. Recommendation for the review of biological reference intervals in medical laboratories. Clin Chem Lab Med 2016;54(12):1893–900
  6. Nisha R, Srinivasa Kannan SR, Thanga Mariappan K, Jagatha P. Biochemical evaluation of creatinine and urea in patients with renal failure undergoing hemodialysis. J Clin Path Lab Med 2017;1(2):1–5
  7. Abd El-Hamid AA, El Gendy SA, Abd El-Gowad ER, El-Rebigi A. Beta-2-microglobulin level in patients with chronic kidney disease. IJAR 2016;4:879–88
  8. Nafar M, Sabaghian, Khoshdel A, Alipour B, Samavat S. Serum calcium and phosphorus levels in hemodialysis patients: a large population-based multicenter study. IRCMJ 2019;21(1):e68772
  9. Rajkumar P, Pluznick JL. Acid-base regulation in the renal proximal tubules: using novel pH sensors to maintain homeostasis. Am J Physiol Renal Physiol 2018;315(5):1187–90
  10. Sacher F, Jesel L, Borni-Duval C, De Precigout V, Lavainne F, Bourdenx JP, et al. Cardiac rhythm disturbances in hemodialysis patients: early detection using an implantable loop recorder and correlation with biological and dialysis parameters. JACC Clin Electrophysiol 2018;4(3):397–408
  11. Raimann JG, Ficociello LH, Usvyat LA, Zhang H, Pacelli L, Moore S, et al. Effects of dialysate to serum sodium (Na+) alignment in chronic hemodialysis (HD) patients: retrospective cohort study from a quality improvement project. BMC Nephrol 2018;19(1):75
  12. Montagud-Marrahi E, Broseta J, Rodriguez-Espinosa D, Lidia R, Hermida-Lama E, Xipell M, et al. Optimization of dialysate bicarbonate in patients treated with online haemodiafiltration. CKJ 2020;1–10
  13. Scarpioni R, Ricardi M, Albertazzi V, De Amicis S, Rastelli F, Zerbini L. Dialysis-related amyloidosis: challenges and solutions. Int J N